OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
CAPSTONE HEALTH SERVICES FOUNDATION PC
850 5TH AVE E
September 23, 2021
Keytruda plus chemotherapy reduces the risk of death by 27% in patients with triple-negative breast cancer.
September 15, 2021
The FDA has set a Prescription Drug User Fee Act target action date of April 30, 2022.
September 13, 2021
Jardiance demonstrated a 21% relative risk reduction for the composite primary endpoint of cardiovascular death or hospitalization for heart failure.
September 10, 2021
Officials with OptumRx predict four new therapies that are expected to an impact on patients and on the market.